Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
The primary goal of this pilot study is to investigate whether psilocybin alters
neuroplasticity in people with major depressive disorder. The primary hypothesis is that
psilocybin will result in neuroplastic changes that parallel improvement in symptoms of
depression.